Screening migrants and travellers for latent tuberculosis: what is new?
- 1 January 2018
- journal article
- editorial
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 25 (1)
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat LatentMycobacterium tuberculosisInfectionMMWR. Morbidity and Mortality Weekly Report, 2018
- LTBI among migrants by Mediterranean Sea: assessing prevalence and its variations according with different thresholds and diagnostic tools. A 10-month on-field experienceJournal of Travel Medicine, 2018
- Health problems of newly arrived migrants and refugees in EuropeJournal of Travel Medicine, 2017
- Infectious diseases and migrant worker health in Singapore: a receiving country’s perspectiveJournal of Travel Medicine, 2017
- Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and ChildrenClinical Infectious Diseases, 2017
- Tuberculosis (NICE clinical guideline 33)Archives of Disease in Childhood - Education & Practice Edition, 2016
- Assessing risk of tuberculosis in international travellers: progress and new challengesJournal of Travel Medicine, 2016
- Revisiting tuberculosis risk in Peace Corps Volunteers, 2006–13Journal of Travel Medicine, 2015
- Effect of a Culture-Based Screening Algorithm on Tuberculosis Incidence in Immigrants and Refugees Bound for the United StatesAnnals of Internal Medicine, 2015